NAT10 and pancreatic neoplasm: In pancreatic cancer research, lncRNA LINC00623 has been shown to bind NAT10 mRNA and recruit the deubiquitinase USP39, preventing its degradation via the ubiquitin-proteasome pathway and consequently elevating NAT10 expression levels (Feng et al., 2022).